MedTrace Logo

Alterations of Gut Microbiota and Serum Biochemical Markers in DILI Patients

NCT05465642 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-08-31

No results posted yet for this study

Summary

Drug-induced liver injury is a leading cause of acute liver failure worldwide and one of the least understood areas in hepatology research. Increasing evidence has shown that drug-induced liver injury is associated with gut microbiota.

Conditions

  • Drug-induced Liver Injury
  • Gut Microbiota
  • Biochemical Markers

Interventions

OTHER

Collect stool and blood samples from patients

Collect stool and blood samples from patients

Sponsors & Collaborators

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Huikuan Chu, M.D. · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, wuhan

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-04
Primary Completion
2024-07-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05465642 on ClinicalTrials.gov